Clinical Genomics Nabs Enterix.

This is a key step in our changeover from a biotech company focused primarily on research and development into a industrial entity with a portfolio of malignancy screening products and a thrilling pipeline, said Lawrence LaPointe, Ph.D., Clinical Genomics’ CEO, in a statement. This article was reprinted from Genetic Engineering & Biotechnology News with authorization from Mary Ann Liebert, Inc., publishers. Genetic Engineering & Biotechnology News provides retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a yr and has additional distinctive editorial content online, like news and analysis and also blogs, podcasts, webinars, polls, video clips, and application notes. GEN’s unique news and technology concentrate includes the entire bioproduct life routine from early-stage R&D, to applied study including omics, biomarkers, and also diagnostics, to commercialization and bioprocessing..Carissa Etienne applauded them, saying: I would like to congratulate the wide range of voluntary actions that your respective businesses took or are considering in order to eliminate industrially-created trans essential fatty acids from your products that are widely available in the region of Latin America and the Caribbean. These actions reveal your willingness to respond to consumer health problems that may also serve to improve consumer self-confidence and enhance brand status. Among companies represented at the conference were Burger King Corporation, Cargill Inc., ConM?xico , Grupo ARCOR, Kraft Foods, Kellogg Company, McDonald’s Company, Nestl?, PepsiCo, SADIA, SA, Watt’s SA and Yum! Brands, Inc.

Other entries from category "physiotherapy":

Random entries